Publications by authors named "Bolong Yu"

Claim this Profile
I
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
Linchong Cui, Zilu Chen, Fangfang Zeng, Xiaolan Jiang, Xiaoyan Han, Xiaofei Yuan, Bolong Yu

BMC Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
Wei Liu, Bolong Yu, Yunfan Luo, Junzheng Li, Xiaofei Yuan, Xinyu Peng

BMC Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective study comparing anti-EGFR monoclonal antibody plus cisplatin-based chemoradiotherapy versus chemoradiotherapy alone for stage II-IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression.
Linwei Mao, Jiajie Tan, Fan Wang, Yunfan Luo, Wei Liu, Bolong Yu

Clin Otolaryngol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Changes in Plasma MicroRNAs Have Potential Predictive Values in Monitoring Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Xia Xu, Juan Lu, Fan Wang, Xiong Liu, Xiaohong Peng, Bolong Yu

Biomed Res Int· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.
Jing Chen, Ji Qi, Bolong Yu, Xiao-Hong Peng, Fan Wang, Xin-Yu Peng

Med Sci Monit· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma.
Fei-Peng Zhao, Xiong Liu, Xiao-Mei Chen, Juan Lu, Bo-Long Yu

Oncol Lett· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical significance of plasma miR-24 dysregulation in nasopharyngeal carcinoma].
Lu Wang, Bolong Yu, Jianhua Cen, Xinyu Peng, Youli Liu

Nan Fang Yi Ke Da Xue Xue Bao· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positivity of both plasma Epstein-Barr virus DNA and serum Epstein-Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma.
Fei-Peng Zhao, Xiong Liu, Zhi-Ming Zhong, Juan Lu, Bo-Long Yu

BBA Clin· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
Bo-Long Yu, Xiao-Hong Peng, Fei-Peng Zhao, Xiong Liu, Juan Lu

Int J Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis